Beam Therapeutics Inc (BEAM) — Capital Reinvestment Ratio
Latest as of December 2023:
0.03x
Beam Therapeutics Inc (BEAM) has a Capital Reinvestment Ratio of 0.03x as of December 2023, meaning it reinvests 0% of its operating cash flow ($135.07 Million) in capital expenditures ($3.59 Million). See Beam Therapeutics Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.03x
Capex / Operating Cash Flow
Operating Cash Flow
$135.07 Million
USD
Capital Expenditures
$3.59 Million
USD
Data as of
Dec 2023
Most recent filing
Beam Therapeutics Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks Beam Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Beam Therapeutics Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for Beam Therapeutics Inc from 2022 to 2022. For live market cap and broader valuation context, see market value of Beam Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.17x | $22.53 Million | $48.95 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow